Passage Bio logo

Passage Bio

PASG | NASDAQ
Chart Builder DCF Calculator
$4.13
-$0.12 (-2.82%)
At close: Nov 16, 2026, 4:00 PM ET
$4.13
$0.00 (0.00%)
After-hours: Nov 16, 2026, 4:10 PM ET
-2.82%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 16, 2026
35.2
Fundamentals Weak
Market Sentiment Bullish
Moat None
Sector Rank #653/1021 (Top 64%)

Key Statistics

Market Data

Market Cap $13.29M
1D Range
3.84 4.20
52W Range
3.32 19.85

Valuation (TTM)

PE -0.40
PB 265.79
EV/EBITDA 0.23

Valuation (NTM)

Forward PE N/A
Forward PEG 0.02
Price Target $8.00
Loading financial charts...

Profile

Passage Bio, Inc. is a biopharmaceutical company dedicated to pioneering genetic therapies for conditions affecting the central nervous system. Their advanced pipeline includes PBGM01, designed to tre...

Sector Healthcare
Industry Biotechnology
Employees 24
IPO Date Feb 28, 2020
Fiscal Year January - December

Latest News

No news articles available yet.

Analyst Summary

# of Analysts
5
Consensus
Hold
Price Target
$8.00
Upside
+93.70%
Buy (2)
Hold (3)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.